INR nthawi zambiri imagwiritsidwa ntchito kuyeza zotsatira za anticoagulants pakamwa pa matenda a thromboembolic.Kutalika kwa INR kumawonedwa mu anticoagulants oral, DIC, kusowa kwa vitamini K, hyperfibrinolysis ndi zina zotero.INR yofupikitsidwa nthawi zambiri imawonedwa mu hypercoagulable states ndi thrombotic disorders.INR, yomwe imadziwikanso kuti International Normalized Ratio, ndi imodzi mwazinthu zoyezera ntchito za coagulation.INR imachokera ku PT reagent kuti iwonetsere International Sensitivity Index ndikuwerengera zotsatira zake kudzera m'njira zina.Ngati INR ndi yokwera kwambiri, pali chiopsezo chotaya magazi osalamulirika.INR imatha kuyang'anira bwino ndikugwiritsa ntchito mphamvu ya anticoagulant.Nthawi zambiri, anticoagulant drug warfarin imagwiritsidwa ntchito, ndipo INR iyenera kuyang'aniridwa nthawi zonse.Muyenera kudziwa kuti ngati warfarin ikugwiritsidwa ntchito, INR iyenera kuyang'aniridwa nthawi zonse.Odwala omwe ali ndi venous thrombosis ayenera kumwa warfarin pakamwa, ndipo mtengo wa INR uyenera kusungidwa pa 2.0-2.5.Kwa odwala atrial fibrillation, mtengo wamkati wa warfarin wapakamwa nthawi zambiri umasungidwa pakati pa 2.0-3.0.Miyezo ya INR pamwamba pa 4.0 ingayambitse magazi osalamulirika, pomwe INR ili pansi pa 2.0 sizipereka anticoagulation yogwira mtima.
Yesani: pitanibe kuchipatala kuti mukayezedwe, ndipo tsatirani dongosolo la dokotala wodziwa bwino ntchito.
Beijing Succeeder wapadera mu thrombosis ndi hemostasis diagnostic mankhwala msika wapadziko lonse.
Monga mmodzi wa zopangidwa kutsogolera China Diagnostic msika wa Thrombosis ndi Hemostasis .SUCCEEDER anakumana magulu a R&D, Kupanga, Marketing Sales ndi Service Supplying coagulation analyzers ndi reagents, magazi rheology analyzers ESR ndi HCT analyzers platelet aggregation analyzers ndi CE ISO1348 ndi FDA Certification olembedwa.
Business khadi
China WeChat
English WeChat